Form D · Pharmaceuticals
OCUCURE THERAPEUTICS INC
Roanoke, VA · CIK 0001361004
Offering snapshot reported May 4, 2017 · SEC filing
- Reported sold
- $100K Offering amount: $100K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $12.5K Reported outside-investor minimum
- First sale
- Mar 14, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 4, 2017 | Initial | $100,002 | No comparison | 4 | SEC filing |
| Oct 6, 2015 | Initial | $200,000 | No comparison | 1 | SEC filing |
| Feb 26, 2014 | Initial | $125,000 | No comparison | 2 | SEC filing |
| Jul 1, 2013 | Initial | $200,000 | No comparison | 0 | SEC filing |
| Jun 21, 2011 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Jun 17, 2010 | Initial | $825,000 | No comparison | 8 | SEC filing |
| Feb 19, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 19, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 13, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 11, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 10, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-286026
Source: Form D, filed May 4, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Harry Davis | Director |
| W. Ben Deibler | Director |
| Ben Deibler | Director |
| George Harvey, Jr. | Director |
| Richard M. Haugen | Director |
| Rick Haugen | Director |
| Sunder H. Malkani | Director, Executive |
| Steve Martin | Director |
| Paul Willams | Director |
| Paul S. Williams | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
15 East Salem Avenue Suite 201
Roanoke, VA, 24011
Roanoke, VA, 24011